Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis.
J Exp Med (1986) 164 (1): 345–350.
Currently there are no citedby results. Try again later.
